![Tomer Natan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomer Natan
Financieel Directeur/CFO bij Quark Pharmaceuticals, Inc.
Profiel
Tomer Natan currently works at Quark Pharmaceuticals, Inc., as Chief Financial Officer from 2005.
Mr. Natan received his graduate degree from Bar-Ilan University and undergraduate degree from The College of Management Academic Studies.
Actieve functies van Tomer Natan
Bedrijven | Functie | Begin |
---|---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Financieel Directeur/CFO | 01-01-2005 |
Opleiding van Tomer Natan
Bar-Ilan University | Graduate Degree |
The College of Management Academic Studies | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Quark Pharmaceuticals, Inc.
![]() Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |